Sato Pharmaceutical Inc. recalls Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. West
Recalled November 20, 2019 · FDA recall D-0322-2020 · Sato Pharmaceutical
Hazard
Subpotent Drug · FDA Class III
Units
21,864 units
Sold at
Nationwide within the United States, Guam and Saipan
Description
Subpotent Drug
Product
Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 49873-803-01. UPC 4987301603
Manufacturer(s)
Sato Pharmaceutical Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →